Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

3,975 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,975 results

Not applicableStudy completedNCT00142155
What this trial is testing

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 300
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Not applicableStudy completedNCT03047616
What this trial is testing

A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663747
What this trial is testing

Enfortumab Vedotin + Pembrolizumab Induction to Spare the Bladder in MIBC

Who this might be right for
Urothelial Bladder Cancer
The Netherlands Cancer Institute 56
Large-scale testing (Phase 3)UnknownNCT01019616
What this trial is testing

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266249
What this trial is testing

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+6 more
ECOG-ACRIN Cancer Research Group 2,175
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07768943
What this trial is testing

GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma

Who this might be right for
Natural Killer/T-cell Lymphoma
Fudan University 620
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableNot Yet RecruitingNCT07685548
What this trial is testing

AI-Driven Tumor Response Evaluation for Solid Tumors

Who this might be right for
Solid Tumor CancerNeoplasmsHepatocellular Carcinoma
Shanghai Zhongshan Hospital 6,120
Early research (Phase 1)Not Yet RecruitingNCT06743555
What this trial is testing

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 14
Not applicableStudy completedNCT00889278
What this trial is testing

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
Dartmouth-Hitchcock Medical Center 30
Not applicableStudy completedNCT06777004
What this trial is testing

Predictive Factors of Analgesic Response in Patients With Pain Associated With Bone Metastasys

Who this might be right for
Cancer Pain
IRCCS Azienda Ospedaliero-Universitaria di Bologna 200
Not applicableEnrolling By InvitationNCT06646263
What this trial is testing

Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies

Who this might be right for
Triple Negative Breast Cancer
Institute of Applied Biosciences 150
Not applicableStudy completedNCT04089748
What this trial is testing

Basal Tumours in Bladder Cancer, Response to chemoTherapy

Who this might be right for
Bladder CancerChemotherapy Effect
University Hospital, Rouen 293
Testing effectiveness (Phase 2)Looking for participantsNCT05599048
What this trial is testing

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Robert Bok, MD, PhD 65
Not applicableStudy completedNCT01631318
What this trial is testing

Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases

Who this might be right for
Liver MetastasesColon Cancer
Stanford University 34
Testing effectiveness (Phase 2)UnknownNCT04082910
What this trial is testing

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Who this might be right for
Solid TumorHematological Malignancy
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Looking for participantsNCT06903858
What this trial is testing

Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal CancerMicrosatellite Instability HighMismatch Repair Deficiency
Sun Yat-sen University 105
Next Page